Evidence map›Paper›PMID 40352791›Full record

ArticleFrontiers in genetics2025

Emerging and evolving values in the changing landscape of genomics.

Maria Siermann, Riya Mohan, Eline M Bunnik, Anne Cambon-Thomsen, Ruth Chadwick, Martina C Cornel, Johannes J M van Delden, Yann Joly, Fruzsina Molnár-Gábor, Maria Pilar Nicolás Jiménez and 8 more

Abstract read
In one paragraph

Article in Frontiers in genetics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Maria Siermann *Centre for Biomedical Ethics and Law, Department of Public Health and Primary Care, KU Leuven, Leuven, Belgium.
Riya Mohan *Centre for Biomedical Ethics and Law, Department of Public Health and Primary Care, KU Leuven, Leuven, Belgium.
Eline M BunnikSection Medical Ethics, Philosophy and History of Medicine, Department of Public Health, Erasmus MC, University Medical Centre Rotterdam, Rotterdam, Netherlands.
Anne Cambon-ThomsenCentre d'épidémiologie et de recherche en santé des populations (CERPOP), UMR 1295, BIOETHICS Team, Institut national de la santé et de la recherche médicale (INSERM), University of Toulouse, Toulouse, France.
Ruth ChadwickSchool of Social Sciences, Cardiff University, Cardiff, United Kingdom.
Martina C CornelDepartment of Human Genetics, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, Netherlands.
Johannes J M van DeldenJulius Center for Health Sciences and Primary Care, University Medical Centre Utrecht, Utrecht, Netherlands.
Yann JolyDepartment of Human Genetics, Centre of Genomics and Policy, Victor Phillip Dahdaleh Institute of Genomic Medicine, McGill University, Montreal, Canada.
Fruzsina Molnár-GáborBioQuant Center and Faculty of Law, Heidelberg University, Heidelberg, Germany.
Maria Pilar Nicolás JiménezFaculty of Law, Chair in Law and the Human Genome Net, University of the Basque Country, Bilbao, Spain.
Wim PinxtenHealthcare and Ethics Group, Faculty of Medicine and Life Sciences, Hasselt University, Hasselt, Belgium.
Emmanuelle Rial-SebbagCentre d'épidémiologie et de recherche en santé des populations (CERPOP), UMR 1295, BIOETHICS Team, Institut national de la santé et de la recherche médicale (INSERM), University of Toulouse, Toulouse, France.
Mahsa ShabaniLaw Centre for Health and Life, Faculty of Law, University of Amsterdam, Amsterdam, Netherlands.
Eva Van SteijvoortCentre for Biomedical Ethics and Law, Department of Public Health and Primary Care, KU Leuven, Leuven, Belgium.
Susan E WallaceDepartment of Health Sciences, University of Leicester, Leicester, United Kingdom.
Ma'n H ZawatiDepartment of Human Genetics, Centre of Genomics and Policy, Victor Phillip Dahdaleh Institute of Genomic Medicine, McGill University, Montreal, Canada.
Bartha Maria KnoppersDepartment of Human Genetics, Centre of Genomics and Policy, Victor Phillip Dahdaleh Institute of Genomic Medicine, McGill University, Montreal, Canada.
Pascal BorryCentre for Biomedical Ethics and Law, Department of Public Health and Primary Care, KU Leuven, Leuven, Belgium.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Recent advances in human genomics have transformed the field, leading to increased integration of genomics into mainstream clinical care, broadening the potential of personalized medicine, and expanding data generation and sharing. From the outset, genetics and genomics have given rise to a broad array of ethical concerns, including issues related to discrimination and stigmatization, informed consent, and reporting requirements of secondary findings. Ethics considerations and trends have evolved in parallel with the rapid technological progress in genomics. Like other transformative technologies, genomic innovations are governed by a combination of laws and ethics guidelines to ensure their responsible implementation. In this manuscript, we propose three key values that are crucial and timely to address now: equity, collective responsibility in the mainstreaming of genomics, and, sustainability. Equity warrants renewed attention due to its critical role in ensuring fair access to genomic innovations and promoting equality within society at large. Collective responsibility in the mainstreaming of genomics is equally important, especially as genomics becomes more broadly available in healthcare and to the broader public, thereby emphasizing shared accountability in its ethical application. Finally, in a context of scarcity of financial, personnel and environmental resources, sustainability needs to be considered to ensure the future of responsible governance in research and healthcare. The goal is to ensure equal access to genomic innovations, promote the ethically responsible use of genomic technologies, and support the long-term sustainability of the field.

Indexed as

collective responsibilityELSIequityethicsgeneticsgenomicssustainability

Identifiers

PMID40352791
PMCPMC12062138

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.